PharmEasy

PharmEasy is an Indian multinational e-pharmacy company that provides services including the sale of medicines online and digital health consultations. The company was founded in 2015 by Dharmil Sheth and Dhaval Shah in Mumbai, India. The startup was initially funded by their parents, before raising VC funding.

In the month of May 2021, they acquired the rival e-pharmacy company Medlife. The transaction involved numbers that were not public knowledge and have not been disclosed.

In June of 2021, they acquired a 66.1% stake in the diagnostics chain Thyrocare for ₹4546 crores. Moving forward, in September of the same year they acquired a stake in Aknamed, a healthcare supply chain company. In November, they filed papers to launch their IPO or Initial public offering of an estimated $800 million, according to livemint.com.

Their current competition includes the likes of Netmeds (under Reliance Industries), 1mg (Under the Tata Group), Apollo 24x7 and Amazon Pharmacy.

The company faced merger protests in 2020. When the companies Medlife and Pharmeasy were in the process of merging together, the Competition Commission of India (CCI) was required to approve the merger. However, the South Chemist and Distributors Association (SCDA) objected to this. Stating that the sale of medicines online was occurring under specific guidelines and regulations in India at the time. In 2021 this issue was resolved with the relaxation of medicine sales guidelines within the country.